Akt/mTOR signalling in myelination

Biochemical Society Transactions

Volumn 41, Issue 4, 2013, Pages 944-950

  Norrmen, Camilla ^a   Suter, Ueli ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Akt; Mammalian (or mechanistic) target of rapamycin (mTOR); Myelination; Oligodendrocyte; Peripheral nervous system (PNS); Schwann cell

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B;

ARTICLE; CENTRAL NERVOUS SYSTEM; DOWNSTREAM PROCESSING; MYELINATION; OLIGODENDROGLIA; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; SCHWANN CELL; SIGNAL TRANSDUCTION;

HUMANS; MYELIN SHEATH; OLIGODENDROGLIA; PROTO-ONCOGENE PROTEINS C-AKT; SCHWANN CELLS; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84880542981     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20130046     Document Type: Article

References (50)

1. Manning, B.D. and Cantley, L.C. (2007) AKT/PKB signaling: navigating downstream. Cell 129, 1261-1274
2. Alessi, D.R., James, S.R., Downes, C.P., Holmes, A.B., Gaffney, P.R., Reese, C.B. and Cohen, P. (1997) Characterization of a 3-phosphoinositide- dependent protein kinase which phosphorylates and activates protein kinase Bα. Curr. Biol. 7, 261-269
3. Guertin, D.A., Stevens, D.M., Thoreen, C.C., Burds, A.A., Kalaany, N.Y., Moffat, J., Brown, M., Fitzgerald, K.J. and Sabatini, D.M. (2006) Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCα, but not S6K1. Dev. Cell 11, 859-871
4. Jacinto, E., Facchinetti, V., Liu, D., Soto, N., Wei, S., Jung, S.Y., Huang, Q., Qin, J. and Su, B. (2006) SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 127, 125-137
5. Sarbassov, D.D., Guertin, D.A., Ali, S.M. and Sabatini, D.M. (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101
6. Laplante, M. and Sabatini, D.M. (2012) mTOR signaling in growth control and disease. Cell 149, 274-293
7. Cornu, M., Albert, V. and Hall, M.N. (2013) mTOR in aging, metabolism, and cancer. Curr. Opin. Genet. Dev. 23, 53-62
8. Thoreen, C.C., Kang, S.A., Chang, J.W., Liu, Q., Zhang, J., Gao, Y., Reichling, L.J., Sim, T., Sabatini, D.M. and Gray, N.S. (2009) An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J. Biol. Chem. 284, 8023-8032
9. Sarbassov, D.D., Ali, S.M., Sengupta, S., Sheen, J.H., Hsu, P.P., Bagley, A.F., Markhard, A.L. and Sabatini, D.M. (2006) Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 22, 159-168
10. Huang, J. and Manning, B.D. (2009) A complex interplay between Akt, TSC2 and the two mTOR complexes. Biochem. Soc. Trans. 37, 217-222
11. Mendoza, M.C., Er, E.E. and Blenis, J. (2011) The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation. Trends Biochem. Sci. 36, 320-328
12. Duvel, K., Yecies, J.L., Menon, S., Raman, P., Lipovsky, A.I., Souza, A.L., Triantafellow, E., Ma, Q., Gorski, R., Cleaver, S. et al. (2010) Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol. Cell 39, 171-183
13. Cunningham, J.T., Rodgers, J.T., Arlow, D.H., Vazquez, F., Mootha, V.K. and Puigserver, P. (2007) mTOR controls mitochondrial oxidative function through a YY1-PGC-1α transcriptional complex. Nature 450, 736-740
14. Kim, J.E. and Chen, J. (2004) Regulation of peroxisome proliferator-activated receptor-γ activity by mammalian target of rapamycin and amino acids in adipogenesis. Diabetes 53, 2748-2756
15. Porstmann, T., Santos, C.R., Griffiths, B., Cully, M., Wu, M., Leevers, S., Griffiths, J.R., Chung, Y.L. and Schulze, A. (2008) SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. Cell Metab. 8, 224-236
16. Harrington, L.S., Findlay, G.M., Gray, A., Tolkacheva, T., Wigfield, S., Rebholz, H., Barnett, J., Leslie, N.R., Cheng, S., Shepherd, P.R. et al. (2004) The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins. J. Cell Biol. 166, 213-223
17. Hsu, P.P., Kang, S.A., Rameseder, J., Zhang, Y., Ottina, K.A., Lim, D., Peterson, T.R., Choi, Y., Gray, N.S., Yaffe, M.B. et al. (2011) The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 332, 1317-1322
18. Yu, Y., Yoon, S.O., Poulogiannis, G., Yang, Q., Ma, X.M., Villen, J., Kubica, N., Hoffman, G.R., Cantley, L.C., Gygi, S.P. and Blenis, J. (2011) Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science 332, 1322-1326
19. Zhang, H., Bajraszewski, N., Wu, E., Wang, H., Moseman, A.P., Dabora, S.L., Griffin, J.D. and Kwiatkowski, D.J. (2007) PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR. J. Clin. Invest. 117, 730-738
20. Dibble, C.C., Asara, J.M. and Manning, B.D. (2009) Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1. Mol. Cell. Biol. 29, 5657-5670
21. Hagiwara, A., Cornu, M., Cybulski, N., Polak, P., Betz, C., Trapani, F., Terracciano, L., Heim, M.H., Ruegg, M.A. and Hall, M.N. (2012) Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. Cell Metab. 15, 725-738
22. Yecies, J.L., Zhang, H.H., Menon, S., Liu, S., Yecies, D., Lipovsky, A.I., Gorgun, C., Kwiatkowski, D.J., Hotamisligil, G.S., Lee, C.H. and Manning, B.D. (2011) Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways. Cell Metab. 14, 21-32
23. Yuan, M., Pino, E., Wu, L., Kacergis, M. and Soukas, A.A. (2012) Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2. J. Biol. Chem. 287, 29579-29588
24. Nave, K.A. and Trapp, B.D. (2008) Axon-glial signaling and the glial support of axon function. Annu. Rev. Neurosci. 31, 535-561
25. Newbern, J. and Birchmeier, C. (2010) Nrg1/ErbB signaling networks in Schwann cell development and myelination. Semin. Cell Dev. Biol. 21, 922-928
26. Pereira, J.A., Lebrun-Julien, F. and Suter, U. (2012) Molecular mechanisms regulating myelination in the peripheral nervous system. Trends Neurosci. 35, 123-134
27. Newbern, J.M., Li, X., Shoemaker, S.E., Zhou, J., Zhong, J., Wu, Y., Bonder, D., Hollenback, S., Coppola, G., Geschwind, D.H. et al. (2011) Specific functions for ERK/MAPK signaling during PNS development. Neuron 69, 91-105
28. Brinkmann, B.G., Agarwal, A., Sereda, M.W., Garratt, A.N., Muller, T., Wende, H., Stassart, R.M., Nawaz, S., Humml, C., Velanac, V. et al. (2008) Neuregulin-1/ErbB signaling serves distinct functions in myelination of the peripheral and central nervous system. Neuron 59, 581-595
29. Goebbels, S., Oltrogge, J.H., Kemper, R., Heilmann, I., Bormuth, I., Wolfer, S., Wichert, S.P., Mobius, W., Liu, X., Lappe-Siefke, C. et al. (2010) Elevated phosphatidylinositol 3,4,5-trisphosphate in glia triggers cell-autonomous membrane wrapping and myelination. J. Neurosci. 30, 8953-8964
30. Goebbels, S., Oltrogge, J.H., Wolfer, S., Wieser, G.L., Nientiedt, T., Pieper, A., Ruhwedel, T., Groszer, M., Sereda, M.W. and Nave, K.A. (2012) Genetic disruption of Pten in a novel mouse model of tomaculous neuropathy. EMBO Mol. Med. 4, 486-499
31. Cotter, L., Ozcelik, M., Jacob, C., Pereira, J.A., Locher, V., Baumann, R., Relvas, J.B., Suter, U. and Tricaud, N. (2010) Dlg1-PTEN interaction regulates myelin thickness to prevent damaging peripheral nerve overmyelination. Science 328, 1415-1418
32. Flores, A.I., Narayanan, S.P., Morse, E.N., Shick, H.E., Yin, X., Kidd, G., Avila, R.L., Kirschner, D.A. and Macklin, W.B. (2008) Constitutively active Akt induces enhanced myelination in the CNS. J. Neurosci. 28, 7174-7183
33. Narayanan, S.P., Flores, A.I., Wang, F. and Macklin, W.B. (2009) Akt signals through the mammalian target of rapamycin pathway to regulate CNS myelination. J. Neurosci. 29, 6860-6870
34. Tyler, W.A., Gangoli, N., Gokina, P., Kim, H.A., Covey, M., Levison, S.W. and Wood, T.L. (2009) Activation of the mammalian target of rapamycin (mTOR) is essential for oligodendrocyte differentiation. J. Neurosci. 29, 6367-6378
35. Hu, X., Schlanger, R., He, W., Macklin, W.B. and Yan, R. (2013) Reversing hypomyelination in BACE1-null mice with Akt-DD overexpression. FASEB J. 27, 1868-1873
36. Zou, J., Zhou, L., Du, X.X., Ji, Y., Xu, J., Tian, J., Jiang, W., Zou, Y., Yu, S., Gan, L. et al. (2011) Rheb1 is required for mTORC1 and myelination in postnatal brain development. Dev. Cell 20, 97-108
37. Wood, T.L., Bercury, K.K., Cifelli, S.E., Mursch, L.E., Min, J., Dai, J. and Macklin, W.B. (2013) mTOR: a link from the extracellular milieu to transcriptional regulation of oligodendrocyte development. ASN NEURO 5, art:e00108.doi:10.1042/AN20120092
38. Sherman, D.L., Krols, M., Wu, L.M., Grove, M., Nave, K.A., Gangloff, Y.G. and Brophy, P.J. (2012) Arrest of myelination and reduced axon growth when Schwann cells lack mTOR. J. Neurosci. 32, 1817-1825
39. Beck, K.D., Powell-Braxton, L., Widmer, H.R., Valverde, J. and Hefti, F. (1995) Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron 14, 717-730
40. Carson, M.J., Behringer, R.R., Brinster, R.L. and McMorris, F.A. (1993) Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Neuron 10, 729-740
41. Russell, J.W., Cheng, H.L. and Golovoy, D. (2000) Insulin-like growth factor-I promotes myelination of peripheral sensory axons. J. Neuropathol. Exp. Neurol. 59, 575-584
42. Gao, W.Q., Shinsky, N., Ingle, G., Beck, K., Elias, K.A. and Powell-Braxton, L. (1999) IGF-I deficient mice show reduced peripheral nerve conduction velocities and decreased axonal diameters and respond to exogenous IGF-I treatment. J. Neurobiol. 39, 142-152
43. Pereira, J.A., Benninger, Y., Baumann, R., Goncalves, A.F., Ozcelik, M., Thurnherr, T., Tricaud, N., Meijer, D., Fassler, R., Suter, U. and Relvas, J.B. (2009) Integrin-linked kinase is required for radial sorting of axons and Schwann cell remyelination in the peripheral nervous system. J. Cell Biol. 185, 147-161
44. Colognato, H., ffrench-Constant, C. and Feltri, M.L. (2005) Human diseases reveal novel roles for neural laminins. Trends Neurosci. 28, 480-486
45. Feltri, M.L., Suter, U. and Relvas, J.B. (2008) The function of RhoGTPases in axon ensheathment and myelination. Glia 56, 1508-1517
46. Kao, S.C., Wu, H., Xie, J., Chang, C.P., Ranish, J.A., Graef, I.A. and Crabtree, G.R. (2009) Calcineurin/NFAT signaling is required for neuregulin-regulated Schwann cell differentiation. Science 323, 651-654
47. He, Y., Kim, J.Y., Dupree, J., Tewari, A., Melendez-Vasquez, C., Svaren, J. and Casaccia, P. (2010) Yy1 as a molecular link between neuregulin and transcriptional modulation of peripheral myelination. Nat. Neurosci. 13, 1472-1480
48. Nadra, K., de Preux Charles, A.S., Medard, J.J., Hendriks, W.T., Han, G.S., Gres, S., Carman, G.M., Saulnier-Blache, J.S., Verheijen, M.H. and Chrast, R. (2008) Phosphatidic acid mediates demyelination in Lpin1 mutant mice. Genes Dev. 22, 1647-1661
49. Verheijen, M.H., Camargo, N., Verdier, V., Nadra, K., de Preux Charles, A.S., Medard, J.J., Luoma, A., Crowther, M., Inouye, H., Shimano, H. et al. (2009) SCAP is required for timely and proper myelin membrane synthesis. Proc. Natl. Acad. Sci. U.S.A. 106, 21383-21388
50. Peterson, T.R., Sengupta, S.S., Harris, T.E., Carmack, A.E., Kang, S.A., Balderas, E., Guertin, D.A., Madden, K.L., Carpenter, A.E., Finck, B.N. and Sabatini, D.M. (2011) mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. Cell 146, 408-420